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Abstract 
Radiation–related changes including fibrosis, nuclear enlargement, hyperchromasia and cy-
toplasmic vacuolization may alter the appearance of normal ovarian tissue and ovarian tumors. 
We describe radiation-related changes in ovarian stromal neoplasm with mixed features of 
sclerosing stromal tumor and fibrothecoma. The right ovarian mass was discovered in a 38 
year-old woman with past history of invasive squamous cell carcinoma of the cervix treated 
with cone biopsy and brachytherapy. The low power architecture of cellular pseudolobules 
and small sheets of tumor cells with scattered hyaline plaques was consisted with the pattern 
of combined sclerosing stromal tumor and fibrothecoma. However, the presence of severe 
cytologic atypia, as well as clear cell and signet ring differentiation and arrangements of tumor 
cells in single files and nests, raised a possibility of primary or metastatic carcinoma. The 
tumor cells were positive for calretinin, vimentin, inhibin, and WT1 and negative for AE1/3, 
cytokeratin 7 and 20, CD99, estrogen and progesterone receptors, mammaglobin, chro-
mogranin, and S100 protein. Based on the results of immunostains and a subsequently pro-
vided history of radiation, a diagnosis of sex cord stromal tumor with mixed fibrothecoma and 
sclerosing stromal differentiation was made. Radiation-related atypia and fibrosis in sex cord 
stromal tumor may create a pattern mimicking carcinoma and therefore, in the presence of 
unusual histology, the use of immunohistochemistry is recommended. 
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Introduction 
The ovary is one of the most radiosensitive or-
gans and its function is affected even with low doses 
of  radiation.  Radiation  treatment  changes  the  ap-
pearance of normal ovarian tissue and ovarian tumors 
and causes ovarian failure (1-3). Typical changes in 
the  normal  ovary  include  destruction  of  primordial 
follicles, stromal fibrosis, and sclerosis of blood ves-
sels.  Radiation  changes  in  benign  and  malignant 
ovarian tumors may create a histologic pattern that is 
difficult to interpret. To our knowledge, there are no 
previous  reports  of  radiation-related  changes  in 
ovarian sex cord-stromal tumors. We present an un-
usual  stromal  neoplasm  with  features  of  sclerosing 
stromal tumor and fibrothecoma (1, 4, 5) in a patient 
previously treated with radiation for carcinoma of the 
cervix. The differential diagnosis and the use of im-
munohistochemical stains are discussed.  
Case Report 
A 38 year-old woman gravida 1 and para 0 pre-
sented  with  a  pelvic  mass  discovered  during  the 
work-up following treatment for cervical cancer. Her Journal of Cancer 2011, 2 
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past  medical  history  included  Stage  IIB  invasive 
squamous cell carcinoma of the cervix, treated with 
cone biopsy and brachytherapy. On an ultrasound, a 
large  heterogeneous  mass  on  the  right  side  of  the 
uterus was identified. A positron-emission tomogra-
phy/computed  tomography  scan  showed  a  hetero-
geneously  enhancing  tumor  arising  from  the  right 
adnexa/broad ligament, with borderline FDG activity 
consistent with benign characteristics. Magnetic res-
onance imaging revealed a 10.1 x 10.1 x 10.2 cm het-
erogeneously  enhancing  right  solid  ovarian  mass. 
With  preoperative  diagnosis  of  ovarian  tumor,  the 
patient  underwent  bilateral  salpingo-oophorectomy. 
The right tubo-ovarian complex weighed 356 grams 
and included ovary replaced by 11.5 X 9.5 x 7.0 cm 
solid mass and an unremarkable fallopian tube. The 
surface of ovarian tumor was tan-pink and smooth, 
with  focal  hemorrhagic  adhesions.  The  cut  sections 
revealed  solid  tan-white  and  nodular,  fleshy  tissue, 
with  multiple  cystic  spaces  filled  with  clear  serous 
fluid (Fig 1A). The opposite ovary and fallopian tube 
were grossly unremarkable.  
 Microscopically,  the  right  ovarian  tumor 
showed  two  different  patterns.  One  consisted  of 
rounded  cellular  pseudolobules  embeded  in  the  fi-
brous  stroma  (Fig  1B),  the  other  of  solid  sheets  or 
separate small nests of tumor cells with scattered hy-
aline plaques (Fig 1C). The pseudolobules contained 
mostly small cells with scant cytoplasm and hyper-
chromatic nuclei, often arranged in cords mimicking 
single files of metastatic lobular carcinoma (Fig 2A). 
The tumor cells forming solid sheets were larger with 
hyperchromatic  nuclei  and  clear,  vacuolated  cyto-
plasm (Fig 2B). In some areas, cytoplasmic vacuoles 
pushed  nuclei  to  the  periphery  creating  signet-ring 
pattern (Fig 2C). The mitotic activity was 0 per 10 high 
power  fields.  Numerous  thick-walled  blood  vessels 
and  areas  of  cystic  degeneration  and  edema  were 
present throughout the tumor. No definite diagnosis 
was  made  on  an  intraoperative  consultation.  Alt-
hough  the  low  power  architecture  favored  stromal 
tumor,  the  high  power  features  especially  cytologic 
atypia, clear cell and signet-ring differentiation were 
suggestive  of  primary  or  metastatic  carcinoma.  The 
results of the immunostains included: positive nuclear 
and cytoplasmic staining for calretinin (Fig 3A), posi-
tive  membranous  and  cytoplasmic  staining  for  vi-
mentin, positive nuclear staining for WT (Fig 3C) and 
focally positive cytoplasmic staining for inhibin 1. The 
immunostains  for  CD99,  epithelial  markers 
(AE1/AE3, CK 7 and CK 20), estrogen receptor (ER), 
progesterone  receptor  (PR),  mammaglobin,  chro-
mogranin, and S100 protein were negative. Based on 
the history of radiation treatment and immunohisto-
chemical profile, a diagnosis of ovarian stromal tumor 
with features of fibrothecoma and sclerosing stromal 
tumor and superimposed radiation effect was made. 
The opposite ovary showed changes consistent with 
status post radiation treatment including stromal fi-
brosis, prominent thick walled blood vessels and foci 
of foamy histiocytes, and hemosiderin-laden macro-
phages.  
 
 
Figure 1. A. Ovarian stromal tumor, gross photograph. B. 
Sclerosing  stromal  tumor  component  (hematoxillin  and 
eosin, original magnification 20 x). C. Fibrothecoma com-
ponent (hematoxillin and eosin, original magnification 20 x).  Journal of Cancer 2011, 2 
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Figure 2. A. “Single file” pattern (hematoxillin and eosin, 
original magnification 40 x). B. “Clear cell” differentiation 
(hematoxillin  and  eosin,  original  magnification  40  x).  C. 
“Signet  ring  cell”  differentiation  (hematoxillin  and  eosin, 
original magnification 40 x). 
 
 
 
 
 
 
 
 
 
Figure 3. A. Positive nuclear and cytoplasmic staining for 
calretinin (original magnification, 40 x). B. Positive cyto-
plasmic staining for vimentin (original magnification 40 x). C. 
Positive nuclear staining for WT1 (original magnification 40 
x). 
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Discussion  
Radiation  treatment  damages  DNA  of  tumor 
cells and surrounding normal tissues. The damage is 
either a direct result of radiation or is due to exposure 
to free radicals produced by the interaction of radia-
tion and water within the cell. Typical morphologic 
changes in tissues subjected to radiation affect both, 
the  epithelium  and  the  stroma  (1-3).  The  nuclei  of 
epithelial  cells  become  enlarged,  pleomorphic  and 
hyperchromatic  and  show  irregular  chromatin 
clumping. The cytoplasm develops granular, vacuo-
lated, or clear appearance due to the dilatation and 
damage of cytoplasmic organelles associated with the 
destruction  of  lysosomes.  The  stromal  changes  in-
clude enlargements of fibroblasts and prominent hya-
linization and thickening of blood vessels. The radio-
sensitivity of individual cells depends on their mitotic 
index. Therefore, the neoplastic cells are more radio-
sensitive than cells of normal tissues. As a result, ra-
diation-related changes alter the appearance of nor-
mal tissues as well as benign and malignant tumors 
and  therefore  may  create  diagnostic  difficulties.
  Since the surgery remains the primary treatment 
for ovarian carcinoma, there are only a few reports 
describing the effects of radiation and chemotherapy 
treatment  on  histology  of  ovarian  tumors  (2,3,6,7). 
McCluggage et al. reported morphologic alterations in 
ovarian serous and endometrioid carcinomas initially 
treated with chemotherapy (6). As in radiation treat-
ment, the changes affected nuclei and cytoplasm of 
tumor cells and the surrounding stroma. There was 
nuclear  enlargement,  irregularity,  hyperchromasia, 
smudging  and  irregular  chromatin  clumping.  The 
cytoplasm  was  either  vacuolated,  foamy  or  deeply 
eosinophilic. There was also prominent stromal fibro-
sis associated with inflammation, fat necrosis, foamy 
histiocytes, cholesterol clefts and hemosiderin laden 
macrophages. It was noted that morphologic altera-
tions made tumor grading and typing very difficult. A 
similar observation was published recently by Chew 
et  al.,  who  described  histologic  changes  in  ovarian 
serous carcinoma treated with chemotherapy (7). As a 
result of the treatment, part of the tumor developed 
“clear cell differentiation.” The distinction from a true 
clear cell carcinoma was based on the results of im-
munostains. 
 Our  case  illustrates  how  radiation  treatment 
may change the appearance of benign ovarian stromal 
tumor  and  create  a  diagnostic  dilemma,  especially 
during  the  intraoperative  examination.  The  cyto-
plasmic vacuolization, nuclear enlargement and hy-
perchromatism  resulting  from  the  radiation  may 
suggest  a  clear  cell  differentiation.  The  prominent 
stromal fibrosis dividing tumor cells into cords and 
small nests may create a pattern mimicking single file 
arrangements of metastatic lobular carcinoma. Final-
ly, the signet-ring differentiation may raise a possibil-
ity Krukenberg tumor.  
Both, our report and the previous studies indi-
cate that iatrogenic changes should always be taken 
into  consideration  when  an  ovarian  tumor  shows 
confusing  and  unusual  features.  Radiation  and 
chemotherapy  can  alter  the  original  histology  and 
make  the  distinction  between  different  histologic 
types of ovarian tumors very difficult. As it is evident 
in our case, sex cord stromal tumors after radiation 
treatment may develop cellular alterations suggestive 
of a carcinoma. In conclusion, it is important to rec-
ognize  radiation  and  chemotherapy  changes,  to  ob-
tain past clinical history, and resort to immunohisto-
chemical stains when necessary. 
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